Trial intelligence / Profile preview

Ampicillin-Sulbactam vs Cefuroxime for C-Section Prophylaxis

NCT01138852Phase 4Completed

Sponsor
Attikon University Hospital
Start
Jul 2004
Primary completion
Dec 2008
Modality
Small Molecules
01

Overview

Phase 4, randomised trial of ampicillin + sulbactam in surgical site infection (SSI) (2 arms), sponsored by Attikon University Hospital. Primary endpoint: Development of an infection either at the surgical site or elsewhere. Started Jul 2004; status: completed.

02

Drugs

ampicillin + sulbactam
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT01138852.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01138852.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call